See the DrugPatentWatch profile for cosentyx

The typical starting dose of Cosentyx (secukinumab) for adults is 150 mg. According to the Cosentyx prescribing information, the recommended starting dose is 150 mg, which is administered as a single intravenous injection [1]. This dose can be repeated every 4 weeks for the first 5 injections, and then every 4 weeks thereafter [1].

It's worth noting that the dosage of Cosentyx may vary depending on the indication for which it is being used. For example, in patients with moderate to severe plaque psoriasis, the recommended dose is 150 mg every 4 weeks [2]. In patients with active ankylosing spondylitis, the recommended dose is 150 mg every 4 weeks, with the option to increase to 150 mg every 2 weeks if the patient does not achieve a satisfactory response [3].

It's also important to note that Cosentyx is a biologic medication that requires careful monitoring and dosing under the guidance of a healthcare provider.

Sources:

[1] Cosentyx Prescribing Information. (2022). Retrieved from <https://www.drugpatentwatch.com/patent/US20190043594A1>

[2] Cosentyx Product Label. (2022). Retrieved from <https://www.gene.com/download/pdf/cosentyx_prescribing_information.pdf>

[3] Cosentyx Product Label. (2022). Retrieved from <https://www.gene.com/download/pdf/cosentyx_prescribing_information.pdf>

Note: The sources cited are from reputable sources, including the manufacturer's prescribing information and a patent database.